M. Jorda

Statistics

Publications

Citations

109

H-Index

Active since

2011

Affiliations

MUSC Hollings Cancer Center(Current)

M. Jorda is an author at MUSC Hollings Cancer Center specializing in neoadjuvant pharmacotherapy, neoadjuvant chemotherapy, and neoadjuvant her2-targeted therapy.

Publications per year

2011–2011

Publications

Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II–IIIc breast cancer

Alberto J. Montero, C. Marcela Díaz‐Montero, Yehuda E. Deutsch et al. · Breast Cancer Research and Treatment · 2011 · 109 citations · Full text

Medicine, Oncology, Pharmacology +14

1–1 of 1